ETOMIDATE POTENTIATION OF GABA(A) RECEPTOR GATED CURRENT DEPENDS ON THE SUBUNIT COMPOSITION

被引:43
作者
UCHIDA, I
KAMATCHI, G
BURT, D
YANG, J
机构
[1] UNIV TEXAS,SW MED CTR,DEPT ANESTHESIOL & PAIN MANAGEMENT,DALLAS,TX 75235
[2] UNIV MARYLAND,SCH MED,DEPT PHARMACOL & EXPTL THERAPEUT,BALTIMORE,MD 21201
关键词
GABA(A) RECEPTOR; GENERAL ANESTHETIC; ETOMIDATE; H293; CELLS; PATCH CLAMP;
D O I
10.1016/0304-3940(95)11263-V
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The role of the gamma 2 subunit in etomidate potentiation of GABA(A) receptor-gated chloride current was studied by whole cell patch clamp experiments on H293 cells expressing GABA(A) receptors. The GABA(A) receptor subunits alpha 1 beta 1 with or without the gamma 2 subunit expressed well, with an overall peak current of 157 +/- 42 pA/pF. At a clinically relevant concentration, etomidate potentiates the peak current induced by GABA equally well in receptors with or without the gamma 2 subunit. In contrast, the time course of current decay was prolonged only in receptors with the gamma 2 subunit. This gamma 2 subunit-dependent prolongation of the current time course was not blocked by the benzodiazepine receptor antagonist flumazenil. These results show that etomidate, an imidazole general anesthetic, interacts with the GABA(A) receptor in a gamma 2 subunit-dependent manner.
引用
收藏
页码:203 / 206
页数:4
相关论文
共 20 条
  • [1] ANGELOTTI TP, 1993, J NEUROSCI, V13, P1429
  • [2] ASHTON D, 1985, ANESTH ANALG, V64, P975
  • [3] ETOMIDATE STEREOSPECIFICALLY STIMULATES FOREBRAIN, BUT NOT CEREBELLAR, DIAZEPAM-H-3 BINDING
    ASHTON, D
    GEERTS, R
    WATERKEYN, C
    LEYSEN, JE
    [J]. LIFE SCIENCES, 1981, 29 (25) : 2631 - 2636
  • [4] FUNCTIONAL AND MOLECULAR DISTINCTION BETWEEN RECOMBINANT RAT GABA-A RECEPTOR SUBTYPES BY ZN-2+
    DRAGUHN, A
    VERDORN, TA
    EWERT, M
    SEEBURG, PH
    SAKMANN, B
    [J]. NEURON, 1990, 5 (06) : 781 - 788
  • [5] GABA-MIMETIC ACTION OF ETOMIDATE
    EVANS, RH
    HILL, RG
    [J]. EXPERIENTIA, 1978, 34 (10): : 1325 - 1327
  • [6] FRNAKS NP, 1994, NATURE, V367, P607
  • [7] GIESE JL, 1983, PHARMACOTHERAPY, V3, P251
  • [8] HARRISON NL, 1993, MOL PHARMACOL, V44, P628
  • [9] HOLLAND KD, 1991, MOL PHARMACOL, V39, P79
  • [10] HORNE AL, 1993, BRIT J PHARMACOL, V108, P711